Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
60.9% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
32
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
31.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
3
users have commented on this narrative
44
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.7% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
6
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Barrick Mining
WA
WaneInvestmentHouse
Community Contributor
Amid Trade War/Tariff – Positioned for Long-Term Upside Amid Strong Fundamentals, Reserve Growth, and Operational Resilience
Barrick Gold Corporation (NYSE: GOLD) presents a compelling investment thesis backed by robust catalysts, thoughtful management execution, and a deeply derisked reserve base that aligns with the evolving dynamics in the gold and copper markets. Catalysts: Reserve Expansion, Strategic Projects & Commodity Tailwinds The key catalyst driving Barrick’s upside is the significant growth in gold and copper reserves , underscoring its exploration success and long-term sustainability.
View narrative
US$20.00
FV
12.7% overvalued
intrinsic discount
20.19%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
15
users have commented on this narrative
34
users have followed this narrative
3 months ago
author updated this narrative
Novo Nordisk
UN
Unike
Community Contributor
Novo Nordisk gears up for explosive growth in weight-loss and diabetes treatments
Catalysts Most Immediate Catalyst (1–2 Years): Weight-Loss Drug Boom: Novo Nordisk’s Wegovy (semaglutide) is dominating the obesity drug market , with demand outpacing supply. Obesity treatment is becoming a major new revenue stream.
View narrative
DKK 1.04k
FV
70.5% undervalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
38
users have followed this narrative
5 months ago
author updated this narrative
Grupo Catalana Occidente
KA
kapirey
Community Contributor
Grupo Catalana Occidente will expand in 2024 with bold acquisitions in Spain and Portugal
Catalysts GCO has 3 lines of business: Occidente dedicated to traditional life non-life and multi-risk insurance, Atradiu s dedicated to commercial credit and Mémora its funeral business line. Mémora continues with its strategy of inorganic growth through acquisitions of local companies in the Iberian Peninsula.
View narrative
€44.88
FV
8.8% overvalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
5 months ago
author updated this narrative
Huhtamäki Oyj
MA
Mandelman
Community Contributor
Stable Margins, Strong Pricing Power - a Mean Reversion Opportunity in Huhtamäki?
Q1 2025 Update Decent revenue and earnings report, numbers supporting a mean reversion play on multiple. Catalysts Strong Pricing Power: Consistent improvement in gross margins, rising from mid-15% levels in early years to nearly 19% in recent projections.
View narrative
€36.42
FV
16.6% undervalued
intrinsic discount
11.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
9
users have followed this narrative
3 months ago
author updated this narrative
Palantir Technologies
HE
HedgeY
Community Contributor
A Key Al-Data Winner but Valuation is a High Hurdle, Launch with a Neutral Rating
UBS; GLOBAL RESEARCH; 18 DEC 2024 Summary We're launching coverage of Palantir shares with a Neutral rating, an $80 price target, 2025/2026 estimates that are well above the Street consensus (+200bps on revs growth) and a very positive view of the fundamentals. We root our views in conversations with 17 large Palantir customers and other checks and offer their unvarnished feedback in this report, which focuses more than we normally would on the core "what exactly does Palantir do?" question, in addition to unpacking the uplift from its Al-Data exposure.
View narrative
US$80.00
FV
116.6% overvalued
intrinsic discount
11.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 months ago
author updated this narrative
Budimex
PH
Phetuvov
Community Contributor
Budimex - a diversified and flexible company
Budimex is the leading Polish company in the construction sector, accounting for about 57% of the overall WIG-construction index. Thanks to the diversification of its operations, the company has been able to occupy such a large share of the market.
View narrative
zł330.00
FV
61.9% overvalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
9 months ago
author updated this narrative
META
Meta Platforms
YI
yiannisz
Community Contributor
Meta’s Bold Bet on AI Pays Off
Meta Platforms, Inc. (META) announced very strong Q3 2024 results underlined by revenue growth and a strong commitment to AI and the metaverse.
View narrative
US$723.11
FV
5.6% overvalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
32
users have followed this narrative
9 months ago
author updated this narrative
AB Volvo
UN
Unike
Community Contributor
Volvo will Accelerate Forward into Electric and Autonomous Leadership in Five Years
Catalysts Most Immediate Catalyst (1–2 Years): Electric Truck & Bus Expansion: Volvo is aggressively expanding its electric truck and bus lineup , capitalizing on increasing demand for zero-emission transport solutions in Europe and North America. Strong Order Book & Pricing Power: Despite macroeconomic concerns, Volvo’s order intake remains robust, with pricing discipline helping offset cost inflation.
View narrative
SEK 438.80
FV
37.8% undervalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
13
users have liked this narrative
5
users have commented on this narrative
36
users have followed this narrative
5 months ago
author updated this narrative
Cosmo Pharmaceuticals
KA
kapirey
Community Contributor
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
Catalysts Preliminary Unaudited Revenue and Cash Revenue: €266.8 million, representing a year-on-year increase of 188% compared to €92.8 million in 2023. This includes significant project-based revenues from GI Genius™ and Winlevi® of €190.2 million.
View narrative
CHF 87.47
FV
36.4% undervalued
intrinsic discount
11.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
83
users have followed this narrative
5 months ago
author updated this narrative
Value any company in seconds
Popular companies